enVVeno Medical wins FDA IDE approval for enVVe pivotal trial in deep venous insufficiencyPUBT·Aug 27 at 01:03 PMNVNO-4.27%
Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments | NVNO Stock NewsStockTitan·Aug 4 at 04:46 AMNVNO-4.27%
enVVeno Medical wins U.S. patent covering enVVe transcatheter venous valve systemPUBT·Jul 7 at 12:29 PMNVNO-4.27%
enVVeno Medical to Present at Webull Corporate Connect Webinar SeriesPUBT·Jun 22 at 01:00 PMNVNO-4.27%
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System | NVNO Stock NewsStockTitan·May 7 at 04:05 AMNVNO-4.27%
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve | NVNO Stock NewsStockTitan·Apr 29 at 04:05 AMNVNO-4.27%
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System | NVNO Stock NewsStockTitan·Mar 27 at 04:30 AMNVNO-4.27%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Feb 20 at 05:05 PMIHI-1.24%ARKG-0.83%
